SpectraScience said today it inked a distribution deal with Kuwait’s Advanced Medical German Co. Through the deal, AMG will operate as SpectraScience’s exclusive distributor for the Middle East region, the San Diego, Calif.-based company said today. “We are pleased to be working with the premier distribution company for gastroenterology in the Middle East. We believe that […]
SpectraScience picks up optical imaging company Oncoscope
SpectraScience said today it acquired the assets of optical imaging system company Oncoscope for an undisclosed amount. Durham, N.C.-based Oncoscope developed a proprietary optical imaging system designed for the minimally invasive detection of pre-cancerous epithelial tissues using scattered white light, with a target indication for Barrett’s Esophagus. “The Oncoscope technology is the perfect complement to […]
Boston Scientific launches Pluromed’s BackStop kidney stone treatment | Wall Street Beat
Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.
Report: J&J set for EU OK on Synthes buyout | Wall Street Beat
European Union regulators are poised to give the OK to Johnson & Johnson‘s (NYSE:JNJ) $21.3 billion acquisition of Swiss orthopedic giant Synthes, according to Reuters.
Is Boston Scientific in line for a private equity takeover? | Wall Street Beat
Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.
iRobot invests $6M into telemedicine company | Funding Roundup
iRobot Corp. (NSDQ: IRBT), famous for their Roomba automated cleaning robots, invested $6 million and launched an extended partnership with InTouch Health, which develops telemedicine systems for providing remote health care.
The venture builds on an existing relationship that the companies announced last summer, under which the companies engaged in a development and licensing agreement.
